Sectors

The ByteDance, Google and Microsoft-backed owner of news aggregator platform DailyHunt was valued above $1bn as of two months ago.

The Eli Lilly-backed liver disease drug developer floated at the top of its range to raise almost $128m, following $207m of venture funding.

Trilantic North America and Energy Impact Partners provided the capital for the Shunfeng Photovoltaic-backed energy storage technology producer.

Today's deal net contains news from Nexthink, Metalenz, Grapheal, CellulaRevolution and Astrata.

Advantech and Momenta Ventures have teamed for a fund set to invest $50m across the artificial intelligence and industrial internet-of-things sectors.

The autonomous driving technology provider has added series C-plus funding to a $376m FAW-backed round in November valuing it above $5bn.

Eli Lilly and WuXi AppTec scored exits from the immunotherapy developer, which has seen its shares rocket 66% since it floated.

The Novo, Pfizer and Nan Fung-backed oncology therapy developer priced an upsized offering above its range and is now valued above $1bn.

Alphabet and Ping An are in line for exits after the online health insurer filed to float on the New York Stock Exchange.

Stanford spinout Bolt Biotherapeutics has raised more than twice as much as originally planned in an offering that also provided exits for corporates Pfizer, Novo and Fan Fung.

Immunocore has raised more than $258m in an upsized offering and an additional $15m in a concurrent private placement.